NCT07598162

Brief Summary

This prospective, randomized, double-blind clinical trial evaluates the comparative effectiveness of ultrasound-guided retrolaminar block (RLB) and erector spinae plane block (ESPB) for postoperative analgesia in patients undergoing laparoscopic cholecystectomy. A total of 100 ASA I-II patients, aged 20-60 years, will be randomly allocated into two equal groups to receive either RLB or ESPB bilaterally following induction of standardized general anesthesia. The primary outcome is the time to first request for rescue analgesia, while secondary outcomes include total morphine consumption within the first 24 hours, postoperative pain scores assessed using the Numeric Rating Scale (NRS), patient satisfaction, and the incidence of adverse events. Pain assessment will be performed at predefined intervals over the first 24 hours postoperatively. The study aims to determine which technique provides superior analgesia with reduced opioid requirements and improved patient outcomes.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
15mo left

Started Apr 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress10%
Apr 2026Sep 2027

Study Start

First participant enrolled

April 1, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 1, 2026

Completed
19 days until next milestone

First Posted

Study publicly available on registry

May 20, 2026

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2027

Last Updated

May 20, 2026

Status Verified

May 1, 2026

Enrollment Period

1.4 years

First QC Date

May 1, 2026

Last Update Submit

May 18, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time to the 1st rescue analgesia

    in the 1st 24hr.

Secondary Outcomes (3)

  • Total morphine consumption

    in the 1st 24hr.

  • Pain score.

    Pain will be assessed at, 2, 4, 6, 8, 12, 18 and 24 hour postoperatively.

  • Degree of patient satisfaction

    in the first 24 hours after surgery

Study Arms (2)

RLB group

ACTIVE COMPARATOR
Biological: Retrolaminar Block (RLB)

ESPB group

ACTIVE COMPARATOR
Procedure: Erector spinae plane block (ESPB)

Interventions

Patients will be positioned laterally, and a curved ultrasound probe will be aligned longitudinally at the T7 vertebra. The vertebral lamina and spinous process will be identified. A needle will be inserted 1 - 1.5 cm lateral to the spinous process, advanced toward the lamina, and 20 mL of LA mixture will be injected into the fascial plane between the lamina and transversus spinae muscles bilaterally.

RLB group

The blocks will be conducted at the level of the T7 spinous process (SP) with the patient in the lateral position and the arm abducted. Using US ( curved probe ) , the T7 transverse process (TP) is identified by counting from the 12th rib. The US probe is positioned 2 - 3 cm laterally to the SP of T7 and situated over the TP of T7/T8 in the parasagittal longitudinal plane, with the erector spinae muscle (ESM) visualized over the TP. The needle is then inserted and advanced in plane from cephalad to caudad until the needle tip contacts the TP of T7. Following hydro dissection with 2 mL of isotonic saline, which elevates the ESM, 20 mL of LA mixture is administered after several negative aspirations.

ESPB group

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age from 20 to 60 years.
  • Both sexes.
  • American Society of Anesthesiology (ASA) grade I and II physical status.
  • Patients will undergo cholecystectomy under general anesthesia.

You may not qualify if:

  • Sensitivities or contraindications to the study medications.
  • Infection at the site of injection.
  • Emergency surgery.
  • Body mass index (BMI) \> 35.
  • Organic comorbidities.
  • Histories of psychological conditions and/or chronic pain syndromes.
  • Contraindications to regional anesthesia.
  • Severe respiratory, cardiac, hepatic and renal disorders.
  • Pregnancy.
  • Coagulopathy.
  • Opioid addiction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sohag Faculty of Medicine

Sohag, Egypt

Location

Central Study Contacts

Esraa abdallah Mohamed, resident

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident of Anesthesia, Surgical Intensive Care and Pain Management Faculty of Medicine, Sohag University

Study Record Dates

First Submitted

May 1, 2026

First Posted

May 20, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

September 1, 2027

Last Updated

May 20, 2026

Record last verified: 2026-05

Locations